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Abstract
Background: Contradictory	results	have	been	reported	previously	in	the	analyses	of	
cross‐reactivity	among	Blomia tropicalis	(Blo	t),	Dermatophagoides pteronyssinus (Der 
p),	and	Dermatophagoides farinae	 (Der	f).	This	study	aims	to	investigate	the	charac‐
teristics	of	co‐sensitization	and	the	 IgE	cross‐reactivity	among	them	and	attempts	
to	 identify	whether	 patients	 are	 sensitized	 to	 Blo	 t	 due	 to	 cross‐reaction	 or	 true	
sensitization.
Methods: Specific	IgE	(sIgE)	in	the	sera	from	1497	allergenic	patients	was	determined	
by	 ImmunoCAP.	 Cross‐reactivity	 was	 analyzed	 and	 determined	 by	 sIgE	 inhibition	
with 21 sera samples.
Results: Around	85.50%	of	patients	were	 sensitized	 to	Der	p,	 85.37%	of	patients	
were	sensitized	to	Der	f,	and	71.54%	of	patients	were	sensitized	to	Blo	t.	Further,	
70.14%	of	 patients	were	 co‐sensitized	 to	Blo	 t,	Der	 p,	 and	Der	 f,	 and	 only	 seven	
patients	were	sensitized	solely	to	Blo	t.	With	increasing	sIgE	levels	for	Blo	t,	the	posi‐
tive	rates	of	severe‐level	 (class	5‐6)	co‐sensitization	to	Der	p	or	Der	f	significantly	
increased.	Blo	t	was	moderately	associated	with	Der	p	and	Der	 f,	with	correlation	
coefficients	of	0.6998	and	0.6782,	respectively.	Der	p	and	Der	f	inhibited	IgE	binding	
to Blo t more strongly than Blo t inhibited IgE binding to Der p or Der f in the patient 
groups	CBlo t	<	CDer p	and	CBlo t	<	CDer f.
Conclusions: This	study	has	established	valuable	information	about	the	co‐sensiti‐
zation	and	cross‐reactivity	of	Blo	t	with	two	Dermatophagoides species (Der p and 
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1  | INTRODUC TION
Mites	are	a	prevalent	and	important	source	of	allergenic	proteins	
that	 are	 associated	 with	 allergic	 respiratory	 diseases,	 such	 as	
asthma and rhinitis. Dermatophagoides pteronyssinus (Der p) and 
Dermatophagoides farinae (Der f) are the predominant mite spe‐
cies	worldwide.	 Yet,	Blomia tropicalis (Blo t) is an important mite 
allergen	in	tropical	regions	like	Singapore,	Malaysia,	Columbia,	and	
the	Taiwan	and	Hainan	provinces	of	China.1‐5	Blo	 t	 coexists	with	
Der	p	and	Der	f,	and	Blo	t‐sensitized	patients	are	usually	co‐sen‐
sitized	to	Der	p	and	Der	f,	with	reports	of	more	than	30%	of	pa‐
tients	sensitized	to	all	three	species.6	Some	studies	have	reported	
a moderate correlation between Der p and Blo t through analysis 
of the levels of specific IgE (sIgE).6‐8	However,	partial	IgE	inhibition	
assays	have	shown	that	Blo	t	allergens	have	little	cross‐reactivity	
with Der p and Der f.9‐11	At	present,	studies	about	cross‐reactivity	
between Blo t and Der p and Blo t and Der f are few and appear 
to	be	inconsistent.	Whether	patients	co‐sensitized	to	Blo	t	and	the	
other	 two	mites	are	due	to	 true	sensitization	or	cross‐reaction	 is	
still	unknown.
Guangzhou,	 a	 capital	 city	 of	 Guangdong	 province,	 located	 in	
Southern	China	 in	subtropical	monsoon	climate	region	that	 is	suit‐
able	for	proliferation	of	dust	mites,	storage	mites,	and	fungi	due	to	
its	warm	and	humid	conditions.	Though	lower	levels	of	Blo	t	antigens	
were found in bedding dust samples and living room samples from 
Guangzhou	city,12 it was found that there was a high positive rate 
(88.2%)	of	Blo	t	in	asthma	patients	with	or	without	rhinitis.13 In our 
study,	we	 investigate	 the	co‐sensitization	and	correlation	of	Blo	 t,	
Der	p,	and	Der	f	using	sIgE	measurements.	SIgE	inhibition	was	used	
to	evaluate	the	IgE	cross‐reactivity	among	these	mites,	attempting	
to	identify	whether	sensitization	to	Blo	t	was	due	to	cross‐reaction	
or	true	sensitization.
2  | MATERIAL S AND METHODS
2.1 | Ethics statement
This	study	was	approved	by	the	Medical	Ethics	Committee	of	The	
First	Affiliated	Hospital	of	Guangzhou	Medical	University	 (ethics	
approval	 no.	 gyfyy‐2016‐73).	All	 experiments	were	performed	 in	
accordance with relevant guidelines and regulations of the Ethics 
Committee	of	The	First	Affiliated	Hospital	of	Guangzhou	Medical	
University.
2.2 | Study subjects
Figure	 1	 shows	 a	 flowchart	 of	 our	 study	 protocol.	 The	 Allergy	
Information	Repository	of	the	State	Key	Laboratory	of	Respiratory	
Der	f)	and	helps	to	provide	adequate	diagnosis	and	treatment	of	the	mite‐allergic	
patients.
K E Y W O R D S
Blomia tropicalis,	cross‐reactivity,	sIgE	inhibition
F I G U R E  1  Study	design	and	flowchart
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Disease	(AIR‐SKLRD)	is	a	large	serum	biobank	containing	serum	from	
allergic	patients	along	with	detailed	clinical	history	and	examination	
records.14,15
There	 were	 1497	 sera	 samples	 from	 mite‐allergic	 patients	
stored	 in	 AIR‐SKLRD,	 which	 were	 selected	 to	 detect	 sIgE	 level	
to	Blo	t,	Der	p,	and	Der	f	and	to	analyze	the	co‐sensitization	and	
correlation	 between	 them.	 These	 patients	were	 sensitized	 to	 at	
least	 one	 mite	 detected	 by	 ImmunoCAP	 method	 (mite	 allergen	
sIgE	 >0.35	 kU/L).	 The	 average	 age	was	 20.01	 ±	 17.51	 years	 old	
(ranging	 from	1	 to	86	years	old),	 and	 there	were	929	males	 and	
568 females.
The	1497	sera	samples	were	divided	into	three	groups	according	
to	the	sIgE	level	to	Blo	t,	Der	p,	and	Der	f,	including	group	CBlo t	>	CDer 
p	 (the	class	of	sIgE	to	Blo	t	was	higher	than	that	of	Der	p,	n	=	35),	
group	CBlo t	=	CDer p (the class of sIgE to Blo t was equal to that of 
Der	p,	n	=	329),	and	group	CBlo t	<	CDer p (the class of sIgE to Blo t was 
lower	than	that	of	Der	p,	n	=	1133).	Of	the	three	groups,	a	total	of	21	
sera	samples	(six	from	group	CBlo t	>	CDer p,	six	from	group	CBlo t	=	CDer 
p,	and	nine	from	group	CBlo t	<	CDer p) were randomly selected for sIgE 
inhibition	assay.	The	characteristics	of	the	study	subjects	selected	in	
the	study	are	shown	in	Table	1.
2.3 | Measurement of sIgE to Blo t, Der p, and Der f
Sera	 sIgE	 to	 Der	 p,	 Der	 f,	 and	 Blo	 t	 was	 measured	 with	 the	
ImmunoCAP	 system	 (Phadia	 1000;	 Thermo	 Fisher	 Scientific	 Inc.)	
according	 to	 the	manufacturer's	 instructions.	 sIgE	 levels	were	 ex‐
pressed	in	kilo	units	per	liter	(kU/L),	and	the	detected	range	of	sIgE	
was	0.1‐100	kU/L.	Any	measurement	over	the	upper	limit	of	the	de‐
tected	range	was	given	a	value	of	100	kU/L.	Tests	with	sIgE	levels	
lower	than	0.35	kU/L	were	defined	as	sIgE‐negative,	otherwise,	they	
were	defined	as	sIgE‐positive.	SIgE‐positive	tests	were	categorized	
into	6	classes:	class	1	(≥0.35‐<0.70	kU/L),	class	2	(≥0.70‐<3.50	kU/L),	
class	 3	 (≥3.50‐<17.50	 kU/L),	 class	 4	 (≥17.50‐<50.00	 kU/L),	 class	 5	
(≥50.00‐<100.00	kU/L),	and	class	6	(≥100.00	kU/L).	Class	1	and	class	
2	were	considered	to	be	mild	sensitization,	class	3	and	class	4	moder‐
ate	sensitization,	and	class	5	and	class	6	severe	sensitization.
2.4 | Crude extract preparation of Blo t, Der p, and 
Der f
Der	p	(lot	number:	327874),	Der	f	(lot	number:	326781),	and	Blo	t	(lot	
number:	287875)	allergens	were	purchased	from	Greer	Laboratories.	
TA B L E  1  Characteristics	of	the	subjects	selected	in	the	study
Patients Gender (M/F) Age (M, IQR) sIgE to Der p (KU/L)
sIgE to Der f 
(KU/L)
sIgE to Blo t 
(KU/L)
IgE analysis 1497 929/568 11 (22) 40.9 (95.95) 44.20 (95.87) 1.57 (5.75)
sIgE inhibition 21 16/5 11 (12.5) 57.5 (63.9) 77.8 (62.55) 34.3 (52.22)
Patients	for	inhibition	
assay
P1 F 51 47.5 87.8 92.4
P2 M 8 >100 >100 13.1
P3 M 59 54.3 >100 >100
P4 M 17 73.8 69.9 10.1
P5 M 13 >100 238 10.9
P6 F 6 95.5 57.8 14.8
P7 M 10 51.7 >100 11.5
P8 M 10 72.2 >100 12.3
P9 M 9 91.8 83 27.8
P10 M 11 70.8 77.8 >100
P11 M 11 2.63 2.28 58.2
P12 M 13 9.1 18.12 67.04
P13 M 7 28.5 35.6 34.3
P14 F 61 31 39.3 25.4
P15 M 40 44.6 >100 82.4
P16 M 11 >100 >100 59.3
P17 M 11 >100 >100 56.1
P18 F 12 61 56.1 62.8
P19 M 5 57.5 50.9 41
P20 M 8 17.1 17.9 10.7
P21 F 25 13.4 11.6 14.1
Abbreviations:	Blo	t,	Blomia tropicalis;	Der	f,	Dermatophagoides farinae;	Der	p,	Dermatophagoides pteronyssinus;	M	(IQR),	median	(interquartile	range);	
M/F,	male/female;	sIgE,	specific	IgE.
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The	allergen	 lyophilized	cakes	were	dissolved	 in	PBS,	aliquoted	 to	
Eppendorf	tubes,	and	stored	at	−80°C	until	used.	Allergen	protein	
concentrations	were	determined	by	BCA	assay	(Pierce™	BCA	protein	
assay).
2.5 | Allergen sIgE inhibition assay
Each serum sample was diluted to test mite sIgE concentration of ap‐
proximately	10	kU/L,	followed	by	mixing	with	equal	volume	of	PBS,	
Blo	t,	Der	p,	and	Der	f	allergen	crude	extract	(2	mg/mL),	respectively.	
After	incubating	at	37°C	and	shaking	for	1	hour,	the	sIgE	levels	were	
measured	by	ImmunoCAP,	and	the	sIgE	inhibition	rate	was	calculated	
using	the	following	formula:	inhibition	rate	=	[(sIgEPBS	−	sIgEallergen)/
sIgEPBS]	×	100%.
2.6 | Statistical analysis
Statistical	 software	 package	 SPSS	 version	 19.0	 was	 used	 to	 ana‐
lyze	 all	 data.	 Parametric	 quantitative	 data	 were	 expressed	 as	 the	
mean	±	standard	deviation.	Non‐parametric	quantitative	data	were	
reported	as	a	median	value	(interquartile	range).	Wilcoxon	matched‐
pairs	 signed‐rank	 test	 was	 used	 to	 compare	 the	 variance	 of	 data	
within	groups,	while	comparison	among	three	groups	was	performed	
with	the	Kruskal‐Wallis	test.	Mann‐Whitney	U test was used to com‐
pare	two	groups.	Correlation	analyses	between	non‐parametric	data	
were	 performed	 using	 Spearman's	 test,	with	 the	 correlation	 coef‐
ficients presented as “rs.” Differences were considered statistically 
significant when P values were <.05.
3  | RESULTS
3.1 | Pattern of sensitization among ImmunoCAP 
positive for Blo t, Der p, and Der f
As	the	Venn	diagram	in	Figure	2	shows,	85.50%	of	patients	were	
sensitized	 to	 Der	 p,	 85.37%	 of	 patients	 were	 sensitized	 to	 Der	
f,	and	71.54%	of	patients	were	sensitized	to	Blo	 t.	Co‐sensitiza‐
tion	was	found	in	70.14%	of	patients	to	these	three	mites.	Almost	
all	Blo	t‐sensitized	patients	were	sensitized	to	Der	p	(1056/1071,	
98.60%)	 or	Der	 f	 (1058/1071,	 98.79%),	 and	only	 seven	patients	
were	sensitized	solely	to	Blo	t.	In	contrast,	82.50%	of	Der	p‐sen‐
sitized	 and	 82.79%	 of	 Der	 f‐sensitized	 patients	 were	 sensitized	
to Blo t.
3.2 | Characteristics of the degree of co‐
sensitization among Blo t, Der p, and Der f
About	50%	of	Blo	t	sIgE‐negative	patients	were	sensitized	to	Der	p	
and	Der	 f,	whereas	of	 the	Blo	 t‐sensitized	 (sIgE‐positive)	 patients,	
only	about	2%	were	sIgE‐negative	to	Der	p	or	Der	f	(Figure	3).	Based	
F I G U R E  2  Pattern	of	sensitization	among	ImmunoCAP	positive	
for	Blo	t,	Der	p,	and	Der	f.	The	numbers	(percentage)	inside	the	
Venn	diagram	show	number	(percentage)	of	patients	who	were	
sensitized	to	one	or	more	mites.	Blo	t,	Blomia tropicalis;	Der	f,	
Dermatophagoides farinae;	Der	p,	Dermatophagoides pteronyssinus
F I G U R E  3  Characteristics	of	the	degree	of	co‐sensitization	among	Blo	t,	Der	p,	and	Der	f.	X‐axis	represents	the	degree	of	mite	
sensitization,	and	Y‐axis	shows	the	proportion	of	co‐sensitization	among	mites	in	different	degree	of	sensitization.	The	co‐sensitization	
proportions	of	one	mite	in	the	same	degree	were	compared	between	groups	with	chi‐square	tests.	Blo	t,	Blomia tropicalis;	Der	f,	
Dermatophagoides farinae;	Der	p,	Dermatophagoides pteronyssinus
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on	the	degree	of	sensitization,	the	patients	were	further	classified	
into	three	subgroups:	mild	(class	1‐2),	moderate	(class	3‐4),	and	se‐
vere	 (class	 5‐6)	 sensitization.	 In	 patients	 co‐sensitized	 with	 Blo	 t	
and	Der	p/Der	f,	as	the	degree	of	Blo	t	sensitization	increased,	the	
percentage	of	 those	who	were	 severely	 sensitized	 to	Der	p/Der	 f	
increased significantly (P	 <	 .001;	 Figure	 3A,B).	 With	 respect	 to	
Der	 p	 and	Der	 f	 (Figure	 3C),	 the	 sIgE‐negative,	mild	 sensitization,	
moderate	 sensitization,	 and	 severe	 sensitization	 consistency	 rates	
were	93.09%	(202/219),	76.87%	(113/143),	74.84%	(348/416),	and	
92.37%	(617/719),	respectively.
3.3 | Spearman correlation among the sIgE level for 
Blo t, Der p, and Der f
The	 results	 of	 the	 spearman	 correlation	 analysis	 are	 shown	 in	
Figure	4.	We	found	that	sensitization	to	Der	p	was	highly	correlated	
with that of Der f (rs	 =	 .9487,	P	 <	 .001),	while	 the	 sensitization	of	
Blo	t	was	moderately	correlated	with	that	of	Der	p	and	Der	f,	with	
correlation coefficients rs of .6998 (P < .001) and .6782 (P	<	 .001),	
respectively.
3.4 | Results of sIgE inhibition assays
Specific	IgE	inhibition	assay	was	performed	among	Blo	t,	Der	p,	and	
Der	 f	with	 21	 individual	 sera	 samples	 from	 patients	 co‐sensitized	
with	mites,	 of	 whom	 the	 sIgE	 concentration	 is	 shown	 in	 Table	 1.	
Table	S1	presents	the	inhibition	rate	of	IgE	against	the	tested	mites	
after	 inhibition	with	Blo	 t,	Der	p,	and	Der	 f	extracts,	 respectively.	
Results	showed	that	all	the	mite	extracts	almost	completely	 inhib‐
ited	their	serum	sIgE	(with	the	median	inhibition	rate	of	>95%).	Der	p	
and	Der	f	inhibited	each	other	with	a	rate	>44%,	whereas	the	mutual	
inhibition rate between Blo t and the two Dermatophagoides species 
was	ranged	from	1%	to	99%	(Table	S1).	Results	showed	that	there	
were significant differences in the inhibition rate of IgE binding to 
mites	with	different	as	well	as	same	inhibitor,	except	for	the	inhibi‐
tion	rate	of	Der	f	inhibiting	Der	p	and	Der	f	inhibiting	Blo	t,	as	well	
as the inhibition rate of Blo t inhibiting Der p and Blo t inhibiting Der 
f (Figure 5).
The	 mutual	 inhibition	 ability	 of	 the	 mites	 was	 compared	 by	
Mann‐Whitney	U	test.	Figure	6A	shows	that	the	inhibition	between	
Der	p	and	Blo	t,	as	well	as	that	between	Der	f	and	Blo	t,	was	signifi‐
cantly different (P	=	.004	and	P	=	.03,	respectively).	Then,	we	divided	
patients into three groups according to the relative class of sIgE. 
Significant	differences	were	found	in	the	patient	groups	CBlo t	<	CDer 
p	and	CBlo t	<	CDer f	(Figure	6B,C).	Those	with	a	positive	inhibition	rate	
(Blo	t	extract	inhibited	IgE	binding	to	Der	p	or	Der	f)	were	lower	than	
the	reverse	one	(Der	p	or	Der	f	extract	inhibited	IgE	binding	to	Blo	
t; P	<	.001).	Four	sera	samples	in	group	CBlo t	>	CDer p and three sera 
samples	in	CBlo t	>	CDer f	had	decreased	reverse	inhibition	rates,	but	
were	not	significantly	different.	In	group	CBlo t	=	CDer p,	the	reverse	
inhibition rates were higher than the positive ones in all sera samples 
but	were	not	statistically	significant	(Figure	6B).	However,	in	group	
CBlo t	=	CDer f,	the	mutual	inhibition	in	the	sera	was	random,	and	there	
was	no	significant	difference	in	(Figure	6C).
In	addition,	eight	sera	samples	from	patients	with	Der	p	and	Der	
f	sIgE‐positive	but	Blo	t	sIgE‐negative	were	selected	for	the	sIgE	in‐
hibition	assay,	and	the	characteristics	and	inhibition	results	of	these	
patients	are	shown	in	Table	S2.
4  | DISCUSSION
In	this	study,	the	prevalence	of	Blo	t,	Der	p,	and	Der	f	was	measured	
in	1497	patients	those	who	were	at	least	sensitized	to	one	mite,	so	
the	sensitization	rates	of	them	in	our	study	were	higher	than	that	of	a	
previous	SPT	research	in	this	area.6	Among	the	mite‐sensitized	sub‐
jects,	>98%	of	patients	were	co‐sensitized	to	at	least	two	mites	(Blo	
t,	Der	p,	and	Der	f),	and	more	than	70%	of	patients	were	sensitized	
to	all	three	mites.	These	data	indicate	that	not	only	Der	p	and	Der	f	
but	also	Blo	t	contributes	to	the	allergic	response	in	Guangzhou.	Blo	
t‐sensitized	patients,	and	those	co‐sensitized	to	Der	p	or	Der	f,	might	
have	multiple	sensitizations	and/or	cross‐reaction.
F I G U R E  4  Spearman	correlation	among	the	sIgE	level	for	Blo	t,	Der	p,	and	Der	f.	Correlation	analyses	between	non‐parametric	data	were	
performed	using	Spearman's	tests,	with	the	correlation	coefficients	presented	as	“rs”.	Blo	t,	Blomia tropicalis;	Der	f,	Dermatophagoides farinae; 
Der	p,	Dermatophagoides pteronyssinus;	sIgE,	specific	IgE
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Within	the	correlation	analysis	of	sIgE,	there	was	a	highly	positive	
correlation	of	sIgE	between	Der	p	and	Der	f,	and	a	moderate	positive	
correlation of sIgE between Blo t and Der p and between Blo t and 
Der	f,	which	fit	well	with	the	findings	of	Kobi	Sade	et	al7	Moreover,	
our	results	showed	that	as	the	severity	of	Blo	t	sensitization	rose,	the	
percentage	of	patients	who	were	co‐sensitized	at	a	severe	level	to	
Der	p/Der	f	also	increased,	indicating	that	cross‐reaction	was	more	
likely	to	account	for	Blo	t	sensitization.	Zheng	et	al12 reported the 
indoor	allergen	 levels	 in	Guangzhou	city	and	showed	that	the	me‐
dian values of Der p 1 and Der f 1 in dust samples from living rooms 
and	beddings	were	0.015‐0.33	μg/g	and	0.12‐5.4	μg/g,	respectively.	
They	also	showed	that	38%	of	dust	samples	from	bedding	had	levels	
of	HDM	allergen	at	or	above	10	μg/g,	while	the	median	level	of	Blo	t	
was	below	the	lower	limit	of	detection,	with	only	3.5%‐27%	of	sam‐
ples	above	the	lower	limit	of	detection.	The	absence	of	Blo	t	allergen	
also supported to our hypothesis that the high prevalence of Blo t 
along	with	co‐sensitization	might	be	because	of	IgE	cross‐reactivity	
toward Dermatophagoides species.
To	 distinguish	 between	 the	 true	 sensitization	 and	 cross‐reac‐
tivity	of	 the	 three	mites,	 21	 sera	 samples	were	 selected	 for	 sIgE	
inhibition.	The	inhibition	between	Der	p	and	Der	f	displayed	a	large	
degree	of	 IgE‐mediated	 cross‐reactivity,	 in	 agreement	with	other	
studies,5,16,17 while the inhibition rate between Blo t and these two 
mites	ranged	from	1%	to	99%,	which	was	inconsistent	with	previ‐
ous studies.5,10	Perhaps,	our	study's	large	sample	size	and	greater	
variety of sIgE classes to Der p and Blo t could account for this 
difference.
To	explain	the	wide	inhibition	rate,	there	was	a	significant	differ‐
ence between the ability of Der p and Der f to inhibit IgE binding to 
Blo t. Der p and Der f could inhibit IgE binding to Blo t better than 
F I G U R E  5  SIgE	inhibition	assays	among	Blo	t,	Der	p,	and	Der	f	with	21	individual	sera.	For	the	convenience	of	labeling	significance,	we	
used	two	diagrams	with	different	layouts.	The	lines	in	the	scatter	dot	plot	denote	median	and	quartiles	level	of	inhibition	rate,	respectively.	
The	yellow,	blue,	and	green	colors	of	symbols	present	Der	p	inhibitor,	Der	f	inhibitor,	and	Blot	inhibitor,	respectively.	The	circle,	triangle,	and	
square	present	the	inhibition	of	IgE	binding	to	Der	p,	Der	f,	and	Blot,	respectively.	Statistical	difference	among	inhibition	rates	of	IgE	against	
tested	mites	with	the	different	mite	inhibitor	(A)	was	determined	by	Wilcoxon	matched‐pairs	signed‐rank	test,	and	statistical	difference	
among	inhibition	rate	of	IgE	binding	to	different	mite	with	the	same	inhibitor	(B)	was	determined	by	Mann‐Whitney	U test. Differences were 
considered statistically significant at P values <.05. *: P	<	.05,	**:	P	<	.01,	***:	P	<	.001.	Blo	t,	Blomia tropicalis;	Der	f,	Dermatophagoides farinae; 
Der	p,	Dermatophagoides pteronyssinus;	sIgE,	specific	IgE
F I G U R E  6  The	mutual	inhibition	ability	of	Blo	t,	Der	p,	and	Der	f.	The	lines	in	(A‐C)	show	the	mutual	inhibition	ability	of	every	two	mites	
of	Blo	t,	Der	p,	and	Der	f	in	the	same	patient.	Statistical	differences	were	determined	by	Mann‐Whitney	U test. Differences were considered 
statistically significant at P values <.05. *: P	<	.05,	**:	P	<	.01,	***:	P	<	.001.	Blo	t,	Blomia tropicalis;	Der	f,	Dermatophagoides farinae;	Der	p,	
Dermatophagoides pteronyssinus;	sIgE,	specific	IgE
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Blo	t	inhibit	Der	p	or	Der	f	in	patients	of	Group	CBlo t	<	CDer p	and	CBlo 
t	<	CDer f.	The	binding	of	Der	p	to	sera	sIgE	could	only	be	inhibited	
by	Blo	t	with	maximum	inhibition	rate	of	60%,	while	Blo	t	sIgE	could	
be	 inhibited	by	Der	 p	 from	50%	 to	99%.	This	 indicates	 that	Blo	 t	
sensitization	in	these	patients	is	more	likely	not	because	of	true	sen‐
sitization	but	cross‐reaction	with	Der	p	and	Der	f.
In	contrast,	for	patients	in	groups	CBlo t	>	CDer p	and	CBlo t	>	CDer 
f,	no	significant	difference	was	revealed	in	the	mutual	inhibition	be‐
tween	Blo	t	and	Der	p,	as	well	as	Blo	t	and	Der	f.	It	seems	that	there	
is	a	subset	of	people	sensitized	to	mites	but	with	the	class	of	sIgE	to	
Blo	t	higher	than	that	of	Der	p	or	Der	f	who	are	sensitized	to	Blo	t	
that	is	not	explained	by	cross‐reactivity	to	Der	p	or	Der	f	exposure.	
In	these	mite‐sensitized	patients,	cross‐reactivity	between	Blo	t	and	
the other two mites is limited.
Furthermore,	we	have	also	selected	eight	patients	who	are	Der	p	
and	Der	f	sIgE‐positive	(Class	of	sIgE	level	≥3)	and	Blo	t	sIgE‐negative	
patients	to	perform	sIgE	inhibition	assay.	Consistent	with	the	results	
of	Kim	et	 al,18 our study showed that the binding of IgE to Der p 
and	Der	f	was	not	inhibited	by	Blo	t,	indicating	that	cross‐reactivity	
between	Der	p/Der	f	and	Blo	t	did	not	contribute	to	the	sensitization	
of	Der	p	or	Der	f	in	these	patients.	Thus,	the	positivity	of	Der	p	and	
Der	f	in	these	patients	was	because	of	true	sensitization.
The	advantages	of	our	study	are	as	follows.	On	one	hand,	a	large	
number	of	allergic	patients	suspected	to	be	sensitized	to	mites	were	
selected	in	our	study,	offering	valuable	information	about	the	IgE	co‐
sensitization	to	the	three	mites.	On	the	other	hand,	the	sera	for	sIgE	
inhibition	assay	(ImmunoCAP)	were	randomly	selected	from	patients	
with	different	degree	of	sensitization	to	Blo	t,	Der	p,	and	Der	f,	which	
made	our	analysis	of	cross‐reactivity	more	comprehensive.	The	lim‐
itation of this study was that the sera for the sIgE inhibition assay 
were	insufficient	because	of	the	small	number	of	patients	in	Group	
CBlo t	>	CDer p	in	Guangzhou	city.	More	individual	sera	are	needed	in	
subsequent sIgE inhibition assays.
5  | CONCLUSIONS
In	conclusion,	sensitization	to	Blo	t	commonly	coexists	with	sensi‐
tization	to	two	Dermatophagoides species (Der p and Der f) and the 
IgE	sensitization	among	them	was	moderately	correlated.	As	for	pa‐
tients	co‐sensitized	to	mites,	those	who	with	the	lower	sIgE	levels	to	
Blo	t	are	more	likely	to	be	caused	by	cross‐reaction,	while	the	higher	
sIgE	level	 in	Blo	t‐sensitized	patients	may	be	due	to	both	of	cross‐
reaction	and	true	sensitization.	SIgE	inhibition	assay	could	be	used	
to	 identify	 cross‐reaction	 or	 true	 sensitization.	 Further	 research	
recognizing	 the	 clear	 cross‐reactive	 components	 of	Blo	 t	 and	 two	
Dermatophagoides species could be performed using recombinant 
allergenic components.
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